| Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis NS El Saghir, MK Khalil, T Eid, AR El Kinge, M Charafeddine, F Geara, ... International journal of surgery 5 (4), 225-233, 2007 | 454 | 2007 |
| Effects of young age at presentation on survival in breast cancer NS El Saghir, M Seoud, MK Khalil, M Charafeddine, ZK Salem, FB Geara, ... BMC cancer 6, 1-8, 2006 | 389 | 2006 |
| Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018 A Shamseddine, A Saleh, M Charafeddine, M Seoud, D Mukherji, ... Population health metrics 12, 1-8, 2014 | 162 | 2014 |
| Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer S Temraz, F Nassar, R Nasr, M Charafeddine, D Mukherji, ... International journal of molecular sciences 20 (17), 4155, 2019 | 118 | 2019 |
| Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective … S Temraz, D Mukherji, ZAA Farhat, R Nasr, M Charafeddine, M Shahait, ... BMC urology 14, 1-6, 2014 | 61 | 2014 |
| Proportion of cancer in a Middle eastern country attributable to established risk factors MA Charafeddine, SH Olson, D Mukherji, SN Temraz, GK Abou-Alfa, ... BMC cancer 17, 1-11, 2017 | 60 | 2017 |
| Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region I Kulhánová, A Znaor, KD Shield, M Arnold, J Vignat, M Charafeddine, ... International journal of cancer 146 (3), 646-656, 2020 | 58 | 2020 |
| Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma A Shamseddine, YH Zeidan, Z El Husseini, M Kreidieh, M Al Darazi, ... Radiation Oncology 15, 1-7, 2020 | 52 | 2020 |
| Programmed death-ligand 1 expression in muscle-invasive bladder cancer cystectomy specimens and lymph node metastasis: a reliable treatment selection biomarker? D Mukherji, MN Jabbour, M Saroufim, S Temraz, R Nasr, M Charafeddine, ... Clinical Genitourinary Cancer 14 (2), 183-187, 2016 | 50 | 2016 |
| Prostate cancer in the Arab world: A view from the inside L Hilal, M Shahait, D Mukherji, M Charafeddine, Z Farhat, S Temraz, ... Clinical genitourinary cancer 13 (6), 505-511, 2015 | 48 | 2015 |
| Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT J El-Cheikh, R Massoud, E Fares, N Kreidieh, R Mahfouz, ... Bone marrow transplantation 52 (6), 918-921, 2017 | 41 | 2017 |
| Survival and Complications of Beta-Thalassemia in LebanonA Decade’s Experience of Centralized Care K Charafeddine, H Isma’eel, M Charafeddine, A Inati, S Koussa, M Naja, ... Acta Haematologica 120 (2), 112-116, 2008 | 39 | 2008 |
| A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer FB Geara, A Shamseddine, A Khalil, M Abboud, M Charafeddine, ... Radiation Oncology 5, 1-8, 2010 | 36 | 2010 |
| Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and … FB Geara, M Bulbul, RB Khauli, TY Andraos, M Abboud, A Al Mousa, ... Radiation Oncology 12, 1-8, 2017 | 33 | 2017 |
| Ki67 and P53 in relation to disease progression in metastatic pancreatic cancer: a single institution analysis S Temraz, A Shamseddine, D Mukherji, M Charafeddine, A Tfayli, H Assi, ... Pathology & Oncology Research 25, 1059-1066, 2019 | 32 | 2019 |
| SO-30 Efficacy and safety of neoadjuvant short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma: Averectal study A Shamseddine, Y Zeidan, Y Bouferraa, R Turfa, J Kattan, D Mukherji, ... Annals of Oncology 32, S215, 2021 | 27 | 2021 |
| High-cost cancer treatment across borders in conflict zones: experience of Iraqi patients in Lebanon M Skelton, R Alameddine, O Saifi, M Hammoud, M Zorkot, M Daher, ... JCO global oncology 6, 59-66, 2020 | 26 | 2020 |
| Hyper-CVAD compared with BFM-like chemotherapy for the treatment of adult acute lymphoblastic leukemia. A retrospective single-center analysis J El-Cheikh, I El Dika, R Massoud, M Charafeddine, R Mahfouz, ... Clinical Lymphoma Myeloma and Leukemia 17 (3), 179-185, 2017 | 23 | 2017 |
| Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation J Jabbour, B Manana, A Zahreddine, C Saade, M Charafeddine, ... Current Research in Translational Medicine 67 (3), 93-99, 2019 | 21 | 2019 |
| Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation R Massoud, R Assi, E Fares, B Haffar, M Charafeddine, N Kreidieh, ... Journal of Clinical Virology 95, 36-41, 2017 | 21 | 2017 |
